Skip Navigation



Home » Drug Information » FDA Approved Drugs » 1997
Medical Areas: Pediatrics/Neonatology | Pulmonary/Respiratory Diseases | Family Medicine

View By:YearCompanyConditionsTherapeutic AreasDrug Names

Flovent Rotadisk

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoSmithKline
Approval Status: Approved November 1997
Treatment Area: asthma

General Information

Flovent Rotadisk, a fluticasone inhalation powder, has been approved for the maintenance treatment of asthma in patients four and older. The corticosteroid is dosed twice daily and is available in strengths of 50 mcg and 100 mcg for children and adults and in a 250 mcg for adults.